PD1^hi CD200^hi CD4⁺ exhausted T cell increase immunotherapy resistance and tumour progression by promoting epithelial-mesenchymal transition in bladder cancer

Wu, Chun1; Duan, Lianhui2; Li, Hongmu1,3; Liu, Xuefei4,5; Cai, Taonong6; Yang, Yang7; Yin, Yuting1; Chang, Wuguang1,3; Zhong, Leqi1,3; Zhang, Lin1,8; Cheng, Yixin1; Qin, Haide9; Wen, Zhesheng1,3; Wang, Huiyun1; Mai, Shijuan1

2023-06-01

10.1002/ctm2.1303

CLINICAL AND TRANSLATIONAL MEDICINE   影响因子和分区

2001-1326

BackgroundBladder cancer (BLCA) is one of the most diagnosed cancers in humans worldwide. Recently, immunotherapy has become a main treatment option for BC. However, most BLCA patients do not respond to immune checkpoint inhibitors or relapse after immunotherapy. Therefore, it is very important to identify novel biomarkers for the prediction of immunotherapy response in B patients. MethodsPancancer single-cell RNA sequencing (scRNA-seq) data were used to identify the clusters of CD4(+) T cells in the tumour microenvironment (TME). The clinical significance of key CD4(+) T-cell clusters was evaluated based on the survival data of two independent immunotherapy bladder cancer (BLCA) cohorts. We also investigated the function of key clusters of CD4(+) T cell in the TME of BC cells in vitro. ResultsThis study identified two novel exhausted CD4(+) T-cell subpopulations with the expression of PD1(hi) CD200(hi) or PD1(hi) CD200(low) in BC patients. Moreover, BLCA patients with a high level of PD1(hi) CD200(hi) CD4(+) exhausted T cell showed immunotherapy resistance. Cell function analysis demonstrated that PD1(hi) CD200(hi) CD4(+) exhausted T cell can promote epithelial-mesenchymal transition (EMT) and angiogenesis in BLCA cells. In addition, PD1(hi) CD200(hi) CD4(+) exhausted T cells were shown to communicate with malignant BLCA cells through the GAS6-AXL axis. Finally, we also found that GAS6 expression is upregulated in B cells by METTL3-mediated m6A modification. ConclusionsPD1(hi) CD200(hi) CD4(+) exhausted T cell may serve as a novel biomarker for poor prognosis and immunotherapy resistance in B. Targeted inhibitors of PD1(hi) CD200(hi) CD4(+) exhausted T cells may help improve the efficacy of immunotherapy.

CD200 CD4 exhausted T cells GAS6 N6-methyladenosine

SCI

英语

通讯

National Natural Science Foundation of China["81772884","82273051","81972640","81871986"]

Oncology ; Research & Experimental Medicine

Oncology ; Medicine, Research & Experimental

WOS:001004246700001

JOHN WILEY & SONS LTD

Web of Science

1.Sun Yat sen Univ, State Key Lab Oncol South China, Canc Ctr, Guangzhou 510060, Peoples R China
2.Zhengzhou Univ, Sch Life Sci, Zhengzhou, Peoples R China
3.Sun Yat Sen Univ, Dept Thorac Oncol, Canc Ctr, Guangzhou, Peoples R China
4.Southern Univ Sci & Technol, Sch Med, Shenzhen 518055, Peoples R China
5.Shenzhen Childrens Hosp, Shenzhen Inst Pediat, Shenzhen, Peoples R China
6.Sun Yat Sen Univ, Dept Urol, Canc Ctr, Guangzhou, Peoples R China
7.Northwest Normal Univ, Sch Geog & Environm Sci, Lanzhou, Peoples R China
8.Sun Yat Sen Univ, Dept Clin Lab, Canc Ctr, Guangzhou, Peoples R China
9.Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Peoples R China

Wu, Chun,Duan, Lianhui,Li, Hongmu,et al. PD1^hi CD200^hi CD4⁺ exhausted T cell increase immunotherapy resistance and tumour progression by promoting epithelial-mesenchymal transition in bladder cancer[J]. CLINICAL AND TRANSLATIONAL MEDICINE,2023,13(6).

Wu, Chun.,Duan, Lianhui.,Li, Hongmu.,Liu, Xuefei.,Cai, Taonong.,...&Mai, Shijuan.(2023).PD1^hi CD200^hi CD4⁺ exhausted T cell increase immunotherapy resistance and tumour progression by promoting epithelial-mesenchymal transition in bladder cancer.CLINICAL AND TRANSLATIONAL MEDICINE,13(6).

Wu, Chun,et al."PD1^hi CD200^hi CD4⁺ exhausted T cell increase immunotherapy resistance and tumour progression by promoting epithelial-mesenchymal transition in bladder cancer".CLINICAL AND TRANSLATIONAL MEDICINE 13.6(2023).